50 assay development scientist jobs at 36 companies in Napa, CA
1w
Save
Mark Applied
Hide
1w
Analytical Assay Development Scientist
Vacaville, California, United States
$100k-$130k/yrOnsiteFull Time
Oath: Develops microbial and AI solutions for soil regeneration and agriculture.
5+ YOEPh.D. or equivalent experience in a relevant science and 5+ years developing quantitative microbial assays; expertise in microbiology methods, complex data analysis, scientific literature, and cross-functional collaboration.
4+ YOEExperience with human iPSC culture and directed differentiation, assay design and execution, molecular biology and imaging, strong data documentation and communication; Bachelor's+6 years or Master's+4 years in related field.
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
1+ YOEMS in biology/biochemistry/cell or related field and 1 year as a development scientist; experience with binding potency assays (ELISA, TR-FRET, Octet, flow cytometry), assay development, SOPs, and scientific reporting.
Senior Associate Scientist, Analytical Development (Contract)
South San Francisco, California, United States
$45-$50/hrOnsiteContract
Allogene TherapeuticsNASDAQ: ALLO: Develops allogeneic cell therapies for cancer and autoimmune diseases
Bachelor's or master's in immunology or cell biology; experience with flow cytometry, cell-based assays, data analysis; authorization to work in the U.S.; 1-year contract with possible extension.
VeracyteNASDAQ: VCYT: Provides genomic diagnostic tests for precise cancer diagnosis.
6+ YOEPhD in molecular biology, genetics, biochemistry, or related field; 6–7 years' postdoctoral and industry experience; NGS assay development, automation, clinical diagnostics, cancer genomics, data analysis, and regulated product development experience.
Next-generation sequencing (NGS), JMP, R, Python, Laboratory Information Management System (LIMS)
Hands-on experience with RNA therapeutics and oligo design; ability to design ASOs/siRNAs, select chemistry, run in vitro/in vivo assays, and analyze PK/PD and efficacy data. Experience with qPCR, RNA-seq, HPLC/UPLC, LC-MS, and related assays.
Denali TherapeuticsNASDAQ: DNLI: Developing treatments for neurodegenerative diseases through brain-delivery technology.
10+ YOEPhD and 10+ years industry/academic experience in biomarker development, regulatory contributions, assay design, data interpretation, and scientific communication.
Addition Therapeutics: Develops RNA-based gene therapies for chronic and rare diseases.
PhD (or equivalent industry experience) in relevant field, proficiency with ELISA, MSD, AlphaLISA, ddPCR, qPCR, Western blot, flow cytometry, microscopy, mammalian cell culture, assay design, troubleshooting, and data communication.
BiogenNASDAQ: BIIB: Biogen develops therapies for neurological and neurodegenerative diseases.
2+ YOEPhD/MS/BS in immunology or related field with industry drug discovery experience; strong hands-on immunology, assay development, in vitro/in vivo and data analysis skills.
SurrozenNasdaq: SRZN: Developing Wnt pathway-modulating therapeutics for tissue repair.
2+ YOEBS/MS/PhD in biology/biochemistry or related; 2–10 years industry experience depending on degree; extensive ADA and PK assay development, serum/plasma/tissue sample analysis, and assay troubleshooting experience.
Pliant TherapeuticsNASDAQ: PLRX: Develops small molecule therapeutics for fibrosis and oncology.
2+ YOEPhD in relevant life science,2+ years industry drug development experience,expertise in cell and in vivo assay design,ability to manage CRO studies and supervise research associates.
qRT-PCR, ELISA, flow cytometry/FACS, Western blot, fluorescent microscopy, immunofluorescence-based staining, Operetta CLS High content imaging, Sony Sorter
Deep Apple Therapeutics: Develops small molecule therapeutics using AI-driven structural biology.
3+ YOEPhD preferred; 3+ years industry experience in small-molecule drug discovery and receptor pharmacology preferred. Experience designing biochemical and cell-based assays, HTS/compound screening, cell culture, and CRO engagement.
General Proximity: Develops proximity-based medicines to treat undruggable disease proteins.
5+ YOEBS/MS/PhD in cell biology or biochemistry; 5-7+ years experience if no PhD; experience with mammalian cells, MOA, signaling, NGS, proteomics; strong communication; CRISPR/Lentiviral, co-IP; cell-based assays.
Olema OncologyNASDAQ: OLMA: Develops targeted therapies for women's cancers.
3+ YOEPhD in a related field, 3+ years industry experience in small-molecule drug discovery, expertise in in vitro assay development, aseptic mammalian cell culture, high-throughput screening and automation, ELN recordkeeping, and strong communication and project management skills.
Microsoft Office, GraphPad Prism, Dotmatics, electronic laboratory notebooks (ELN), robotic liquid-handling automation tools, automated systems (liquid handlers)
Prolific Machines: Controls cell behavior with light to optimize biomanufacturing.
1+ YOEPhD (preferred) in relevant field or equivalent industry experience; 1+ years biologics industry experience; assay development and protein characterization (HPLC, LC-MS, charge/aggregation, PTM); GLP method experience; hands-on LC-MS/Agilent QTOF; strong communication.
Sr Scientist/Principal Scientist, Discovery Oncology (in vivo Biology)
South San Francisco, California, United States
$71k-$187k/yrOnsiteFull Time
Eli Lilly and CompanyNYSE: LLY: Researches and manufactures medicines for human health.
3+ YOEDesign and execute in vivo mouse and rat studies, support ex vivo/in vitro assays, analyze data; BS with 3–5 years or MS with 5–8 years lab experience; authorization to work in US required.
NateraNASDAQ: NTRA: Provides clinical genetic testing and diagnostics services.
4+ YOEBSc with 4+ years (or MSc with 2+ years) in molecular biology/biochemistry, hands-on NGS and DNA/RNA workflows, library prep, qPCR, data analysis (R/JMP/Excel), pipetting and assay development experience.